Nymox Pharmaceutical Corp – ‘20-F’ for 12/31/15

On:  Wednesday, 3/30/16, at 9:42pm ET   ·   As of:  3/31/16   ·   For:  12/31/15   ·   Accession #:  1176256-16-495   ·   File #:  1-12033

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report by a Foreign Private Issuer   —   Form 20-F
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report for the Fiscal Year Ended December    HTML    836K 
                          31, 2015                                               
 2: EX-4.W      Common Stock Private Purchase Agreement Dated       HTML    105K 
                          November 1, 2013                                       
 3: EX-4.X      6% Secured Convertible Note Dated December 16,      HTML     54K 
                          2014                                                   
 4: EX-4.Y      Response Letter From Kpmg in the Corporation's 6-K  HTML     31K 
                          Dated July 16, 2015                                    
 7: EX-13.A     Sox Section 906 CEO Certification                   HTML      7K 
 8: EX-13.B     Sox Section 906 CFO Certification                   HTML      7K 
 5: EX-12.A     Sox Section 302 CEO Certification                   HTML     11K 
 6: EX-12.B     Sox Section 302 CFO Certification                   HTML     12K 

        

To view the SGML, please refresh this page.